Growth Inhibition of Human Colon Cancer Cells by Nitric Oxide (NO) -Donating Aspirin Is Associated with Cyclooxygenase-2 Induction and β-Catenin/T-Cell Factor Signaling, Nuclear Factor-κB, and NO Synthase 2 Inhibition: Implications for Chemoprevention

Cancer Research

Volumn 63, Issue 22, 2003, Pages 7613-7618

  Williams, Jennie L ^a,b   Nath, Niharika ^c   Chen, Jie ^a   Hundley, Thomas R ^a,b   Gao, Jianjun ^a   Kopelovich, Levy ^d   Kashfi, Khosrow ^c   Rigas, Basil ^a,b  

^a AMERICAN HEALTH FOUNDATION   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (ACETYLOXY)BENZOIC ACID 4 (NITROOXYMETHYL)PHENYL ESTER; ACETYLSALICYLIC ACID DERIVATIVE; BETA CATENIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NCX 4040; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL GROWTH; COLON CANCER; COLON CARCINOGENESIS; CONJUGATE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEACETYLATION; DRUG EFFECT; DRUG METABOLISM; ENZYME INDUCTION; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TUMOR CELL CULTURE;

ASPIRIN; BETA CATENIN; CELL NUCLEUS; COLONIC NEOPLASMS; CYCLIC GMP; CYCLOOXYGENASE 2; CYTOSKELETAL PROTEINS; DNA, NEOPLASM; HT29 CELLS; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; NF-KAPPA B; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0345275877     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Rigas, B., and Williams, J. L. NO-releasing NSAIDs and colon cancer chemoprevention: a promising novel approach. Int. J. Oncol., 20: 885-890, 2002.
2. Fiorucci, S., Santucci, L., Gresele, P., Faccino. R. M., Del Soldato, P., and Morelli, A. Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study. Gastroenterology, 124: 600-607, 2003.
3. Williams, J. L., Borgo, S., Hasan, I., Castillo, E., Traganos, F., and Rigas, B. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention. Cancer Res., 61: 3285-3289, 2001.
4. Bak, A. W., McKnight, W., Li, P., Del Soldato, P., Calignano, A., Cirino, G., and Wallace, J. L. Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma. Life Sci., 62: 367-373, 1998.
5. Rao, C. V., Cooma, I., Rigas, B., Kopelovich, L., and Reddy, B. S. Chemoprevention of colonic aberrant crypt foci by nitric oxide (NO) releasing NSAIDs (abstract). American Association for Cancer Research (AACR) Annual Meeting: 2002 Frontiers in Cancer Prevention Research. October 14-19, 2002, Sheraton Boston Hotel, Boston.
6. Kashfi, K., Ryan, Y., Qiao, L. L., Williams, J. L., Chen, J., Del Soldato, P., Traganos, F., Rigas, B., and Ryann, Y. Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect. J. Pharmacol. Exp. Ther., 303: 1273-1282, 2002.
7. Oving, I. M., and Clevers, H. C. Molecular causes of colon cancer. Eur. J. Clin. Investig., 32: 448-457, 2002.
8. Chiang, J. M., Chou, Y. H., Chen. T. C., Ng, K. F., and Lin, J. L. Nuclear β-catenin expression is closely related to ulcerative growth of colorectal carcinoma. Br. J. Cancer. 86: 1124-1129, 2002.
9. Ougolkov, A. V., Yamashita, K., Mal, M., and Minamoto, T. Oncogenic β-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer. Gastroenterology, 122: 60-71, 2002.
10. Hao, X. P., Pretlow. T. G., Rao, J. S., and Pretlow, T. P. β-Catenin expression is altered in human colonic aberrant crypt foci. Cancer Res., 61: 8085-8088, 2001.
11. Dihlmann, S., Siermann, A., and von Knebel Doeberitz, M. The nonsteroidal antiinflammatory drugs aspirin and indomethacin attenuate β-catenin/TCF-4 signaling. Oncogene, 20: 645-653, 2001.
12. Richmond, A. Nf-κB, chemokine gene transcription and tumour growth. Nat. Rev. Immunol., 2: 664-674, 2002.
13. Marnett, L. J., and DuBois, R. N. COX-2: a target for colon cancer prevention. Annu. Rev. Pharmacol. Toxicol., 42: 55-80, 2002.
14. Fiorucci, S., Santucci, L., Cirino, G., Mencarelli, A., Familiari, L., Soldato, P. D., and Morelli, A. IL-1β converting enzyme is a target for nitric oxide-releasing aspirin: new insights in the antiinflammatory mechanism of nitric oxide-releasing nonsteroidal antiinflammatory drugs. J. Immunol., 165: 5245-5254, 2000.
15. Minuz, P., Degan, M., Gaino, S., Meneguzzi, A., Zuliani, V., Santonastaso, C. L., Soldato, P. D., and Lechi, A. NCX4016 (NO-aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes. Br. J. Pharmacol., 134: 905-911, 2001.
16. 2-terminal kinase 1. Clin. Cancer Res., 6: 4136-4141, 2000.
17. Stark, L. A., Din, F. V., Zwacka, R. M., and Dunlop, M. G. Aspirin-induced activation of the NF-κB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells. FASEB J., 15: 1273-1275, 2001.
18. Felley-Bosco, E., Bender, F. C., Courjault-Gautier, F., Bron, C., and Quest, A. F. Caveolin-1 down-regulates inducible nitric oxide synthase via the proteasome pathway in human colon carcinoma cells. Proc. Natl. Acad. Sci. USA, 97: 14334-14339, 2000.
19. Hanif, R., Pittas, A., Feng, Y., Koutsos, M. I., Shiff, S. J., Staiano-Coico, L., Shiff, S. I., and Rigas, B. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol., 52: 237-245, 1966.
20. Rao. C. V., Kawamori, T., Hamid, R., and Reddy, B. S. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. Carcinogenesis (Lond.), 20: 641-644, 1999.
21. Kopp, E., and Ghosh, S. Inhibition of NF-κB by sodium salicylate and aspirin. Science (Wash. DC), 265: 956-959, 1994.
22. Amann, R., and Peskar. B. A. Anti-inflammatory effects of aspirin and sodium salicylate. Eur. Pharmacol., 447: 1-9, 2002.
23. Araki, Y., Okamura, S., Hussain, S. P., Nagashima, M., He, P., Shiseki, M., Miura, K., and Harris, C. C. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways. Cancer Res., 63: 728-734, 2003.
24. Fiorucci, S., Mencarelli, A., Meneguzzi, A., Lechi, A., Morelli, A., del Soldato, P., and Minuz, P. NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide. Circulation, 106: 3120-3125, 2002.
25. , Qiao. L., Kozoni, V., Tsioulias, G. J., Koutsos, M. I., Hanif, R., Shiff, S. J., and Rigas, B. Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. Biochim. Biophys. Acta, 1258: 215-223, 1995.
26. Peng, H. B., Libby, P., and Liao, J. K. Induction and stabilization of IκBα by nitric oxide mediates inhibition of NF-κB. J. Biol. Chem., 270: 14214-14219, 1995.
27. Shiff, S. J., and Rigas, B. The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs). J. Exp. Med., 190: 445-450, 1999.